STANDUP-HF (Completed)
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Ranging,
Phase 2b Study of the Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of
BMS-986231 in Hospitalized Patients with HF and Impaired Systoli
- Medicine
- BMS-986231
- Population
- Heart failure
- Phase
- II
- Starting year
- 2016